Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Aronson

Showing results (371-380 of 634) with videos related to

Pageof 64
Sort By:
Drug Safety|October 8, 2010
Preventability of drug-related harms - part I: a systematic reviewRobin E Ferner, Jeffrey K Aronson
Drug Safety|October 8, 2010
Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactionsJeffrey K Aronson, Robin E Ferner
BMJ (Clinical Research Ed.)|July 3, 2004
The road to health careLuis Gabriel Cuervo, Jeffrey K Aronson
Dermatologic Therapy|July 30, 2010
PanniculitisIris K Aronson, Sophie M Worobec
QJM : Monthly Journal of the Association of Physicians|December 1, 1996
Iatrogenic chest pain: a case of 5-fluorouracil cardiotoxicityI S Farooqi, J K Aronson
Trials|April 29, 2025
Clinical Study Reports-a systematic review with thematic synthesis: Part 1. History, contents and structure, definitions, and terminologyJ K Aronson, I J Onakpoya
BMJ (Clinical Research Ed.)|November 25, 2003
Joining the DoTS: new approach to classifying adverse drug reactionsJ K Aronson, R E Ferner
Lancet (London, England)|April 18, 2000
Medication errors, worse than a crimeR E Ferner, J K Aronson
BMJ (Clinical Research Ed.)|December 12, 1992
ABC of monitoring drug therapy. CyclosporinD J Reynolds, J K Aronson
Dermatologic Therapy|July 30, 2010
Cytophagic histiocytic panniculitis and hemophagocytic lymphohistiocytosis: an overviewIris K Aronson, Sophie M Worobec
Pageof 64

Showing results (371-380 of 634) with videos related to

Sort By:
Pageof 64
Drug Safety|October 8, 2010
Preventability of drug-related harms - part I: a systematic reviewRobin E Ferner, Jeffrey K Aronson
Drug Safety|October 8, 2010
Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactionsJeffrey K Aronson, Robin E Ferner
BMJ (Clinical Research Ed.)|July 3, 2004
The road to health careLuis Gabriel Cuervo, Jeffrey K Aronson
Dermatologic Therapy|July 30, 2010
PanniculitisIris K Aronson, Sophie M Worobec
QJM : Monthly Journal of the Association of Physicians|December 1, 1996
Iatrogenic chest pain: a case of 5-fluorouracil cardiotoxicityI S Farooqi, J K Aronson
Trials|April 29, 2025
Clinical Study Reports-a systematic review with thematic synthesis: Part 1. History, contents and structure, definitions, and terminologyJ K Aronson, I J Onakpoya
BMJ (Clinical Research Ed.)|November 25, 2003
Joining the DoTS: new approach to classifying adverse drug reactionsJ K Aronson, R E Ferner
Lancet (London, England)|April 18, 2000
Medication errors, worse than a crimeR E Ferner, J K Aronson
BMJ (Clinical Research Ed.)|December 12, 1992
ABC of monitoring drug therapy. CyclosporinD J Reynolds, J K Aronson
Dermatologic Therapy|July 30, 2010
Cytophagic histiocytic panniculitis and hemophagocytic lymphohistiocytosis: an overviewIris K Aronson, Sophie M Worobec
Pageof 64